1. Home
  2. IMNN vs ECDA Comparison

IMNN vs ECDA Comparison

Compare IMNN & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • ECDA
  • Stock Information
  • Founded
  • IMNN 1982
  • ECDA 2013
  • Country
  • IMNN United States
  • ECDA United States
  • Employees
  • IMNN N/A
  • ECDA N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • ECDA Auto Manufacturing
  • Sector
  • IMNN Health Care
  • ECDA Consumer Discretionary
  • Exchange
  • IMNN Nasdaq
  • ECDA Nasdaq
  • Market Cap
  • IMNN 12.1M
  • ECDA 11.2M
  • IPO Year
  • IMNN 1985
  • ECDA N/A
  • Fundamental
  • Price
  • IMNN $0.60
  • ECDA $0.36
  • Analyst Decision
  • IMNN Strong Buy
  • ECDA
  • Analyst Count
  • IMNN 2
  • ECDA 0
  • Target Price
  • IMNN $15.50
  • ECDA N/A
  • AVG Volume (30 Days)
  • IMNN 237.6K
  • ECDA 725.8K
  • Earning Date
  • IMNN 05-12-2025
  • ECDA 06-27-2025
  • Dividend Yield
  • IMNN N/A
  • ECDA N/A
  • EPS Growth
  • IMNN N/A
  • ECDA N/A
  • EPS
  • IMNN N/A
  • ECDA N/A
  • Revenue
  • IMNN N/A
  • ECDA $25,165,733.00
  • Revenue This Year
  • IMNN N/A
  • ECDA $21.59
  • Revenue Next Year
  • IMNN N/A
  • ECDA N/A
  • P/E Ratio
  • IMNN N/A
  • ECDA N/A
  • Revenue Growth
  • IMNN N/A
  • ECDA 29.10
  • 52 Week Low
  • IMNN $0.64
  • ECDA $0.29
  • 52 Week High
  • IMNN $3.65
  • ECDA $1.45
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 24.71
  • ECDA 42.49
  • Support Level
  • IMNN $0.60
  • ECDA $0.33
  • Resistance Level
  • IMNN $1.08
  • ECDA $0.53
  • Average True Range (ATR)
  • IMNN 0.08
  • ECDA 0.07
  • MACD
  • IMNN -0.02
  • ECDA 0.02
  • Stochastic Oscillator
  • IMNN 3.12
  • ECDA 28.93

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: